Objective: To elucidate the responsible mechanisms of increased slope of minute ventilation relative to carbon dioxide production (V E/V CO 2 ) during exercise after acute myocardial infarction without overt signs of heart failure, patients who had an acute myocardial infarction were examined after participating in a three month supervised exercise training programme. Design: Exercise testing, hypercapnic CO 2 chemosensitivity measurement (rebreathing method), and pulmonary function test were repeated at entry and after three months in 50 acute myocardial infarction patients with neither symptoms nor signs of heart failure who completed the training programme.
xercise hyperventilation characteristic of patients with chronic heart failure may contribute to their exercise intolerance. It can be estimated by an increased minute ventilation relative to carbon dioxide (CO 2 ) production (ṼE/ṼCO 2 slope), which is known to be related to the severity of heart disease. Furthermore, this index has recently received increasing attention since it is a powerful prognostic marker independent of peak oxygen uptake (ṼO 2 ) and left ventricular function. 1 2 Several factors such as inefficient ventilation (perfusion-ventilation mismatch, rapid-shallow respiratory pattern), [3] [4] [5] [6] [7] [8] [9] alteration in CO 2 chemosensitivity, 10 ergoreflex overactivation, [11] [12] [13] [14] and possibly reduced alveolar-capillary membrane diffusing capacity (carbon monoxide transfer factor (TLCO)) 15 16 are thought to be responsible for exercise hyperventilation, although the details remain unsettled.
Intriguingly, exercise training, the most potent means of improving exercise intolerance, ameliorates exercise hyperventilation in patients with chronic heart failure. 17 18 Although exercise hyperventilation has been believed to be characteristic of chronic heart failure, several studies have suggested that the presence of chronic heart failure is not necessarily a prerequisite for this phenomenon. 19 20 We also have recently reported that, even in the absence of overt heart failure, some patients with acute myocardial infarction exhibited an increased ṼE/ṼCO 2 slope, which was attenuated after an exercise training programme. 21 The underlying mechanism(s) for the above results remain undetermined, however. Because it is unlikely that these patients have perfusion-ventilation mismatch or rapid-shallow ventilation pattern during exercise, and because ergoreflex overactivation, probably caused by prolonged inactivity, does not appear to occur in these patients, we can postulate that these results may be associated with alteration in CO 2 chemosensitivity through unknown mechanisms such as excessive sympathetic tone, which has been observed in these patients and has been implicated as a factor of accelerated ventilation. [22] [23] [24] We therefore measured exercise ventilation, hypercapnic CO 2 chemosensitivity, and respiratory function, including TLCO, before and after a three month exercise training programme in patients with acute myocardial infarction. The purpose of the present study was twofold: firstly, to evaluate the determinants of an increased ṼE/ṼCO 2 slope in patients with acute myocardial infarction but with neither symptoms nor signs of heart failure; and, secondly, to examine the hypothesis that alteration in CO 2 chemosensitivity contributes to the attenuation of the ṼE/ṼCO 2 slope after exercise training.
METHODS

Study population
Among patients who were admitted to the coronary care unit of our hospital for the diagnosis of acute myocardial infarction, 60 consecutive patients were enrolled into this study. They subsequently (during hospitalisation) participated in the supervised exercise training programme at our rehabilitation institute and consented to take part in the study (table  1) . The mean (SD) interval between the onset of myocardial infarction and entry into the programme was 13 (4) days (median 13 days). Forty three of the 60 patients (72%) received revascularisation in the acute phase of infarction. In the acute phase, eight patients had transient haemodynamic impairment defined as a grade of subset II or greater according to the Forrester classification. At entry, no patients had postinfarct angina, symptoms of heart failure, or clinical evidence of residual ischaemia during exercise testing. Left ventricular ejection fraction (LVEF) determined by contrast left ventriculography before discharge was 44 (9)% (range 19-59%). There were five patients with low LVEF of < 30% but all patients, including these five, had neither symptoms nor signs of heart failure. Only two patients had a previous myocardial infarction. Patients with primary lung disease or vascular or orthopaedic problems of the lower extremities that precluded exercise training were excluded from the study.
Fifty patients who completed the supervised exercise training programme three to five times a week for three months were assigned to the training group. The other 10 patients, who performed the initial low intensity exercise during admission (two weeks) but discontinued the training after hospital discharge, served as controls (group C). The reason for the early discontinuation was not a medical problem in any patient of group C (reasons were occupational or social problems and living a long distances from our institute). No patients in group C engaged in regular exercise after discharge. Because our previous study 21 had indicated that attenuation of the ṼE/ṼCO 2 slope after exercise training was found only in patients with increased baseline (pretraining) values of ṼE/ṼCO 2 , we divided 50 patients into two subgroups according to the value of ṼE/ṼCO 2 measured at pretraining exercise testing. Group T Low consisted of 27 patients with pretraining ṼE/ṼCO 2 < 30 and group T High of 23 patients with pretraining ṼE/ṼCO 2 > 30. The cut off value of ṼE/ṼCO 2 (= 30) was determined based on our previous study. 21 Drug regimens were not altered throughout the study.
Symptom limited exercise testing, pulmonary function testing, and measurement of CO 2 chemosensitivity were repeated at entry into the training programme and three months later in all 60 subjects. The three tests were performed on the same day: exercise testing was followed by pulmonary function testing and measurement of CO 2 chemosensitivity after at least 30 minutes of rest. The first and second examinations were conducted 19 (14) days (median 17 days) and 111 (23) days (median 108 days) after the onset of myocardial infarction, respectively. All subjects gave written informed consent for the study.
Exercise test with gas analysis Symptom limited exercise testing with simultaneous gas analysis (AE-280, Minato Medical Science, Osaka, Japan) was performed on an electronically braked ergometer (Examiner 400, Lode, Groningen, The Netherlands) in the upright position. After unloaded bicycling (0 W) for one minute, exercise intensity was increased in a ramp fashion (15 W/min) until exhaustion in terms of dyspnoea or fatigue. Subjects were constantly encouraged to make their maximal efforts. ECGs were continuously monitored throughout the test. Arterial blood pressure was measured by cuff sphygmomanometer every minute during exercise and 1-2 minutes during recovery. Peak ṼO 2 was determined as the averaged ṼO 2 over 18 seconds before the termination of exercise. The slope of the linear regression relating minute ventilation to CO 2 output between the beginning of the exercise and the respiratory compensation point was used as the index of the ventilatory response to exercise (ṼE/ṼCO 2 slope). 7 8 Pulmonary function test Standard measurements of forced expiratory volume in one second (FEV 1 ) and vital capacity (VC) were made with FUDAC-70 (Fukuda Denshi Co Ltd, Tokyo, Japan). Pulmonary carbon monoxide diffusion (TLCO) was measured using a single breath technique. These data were expressed as a percentage of predicted normal values (%FEV 1 , %VC, and %TLCO) on the basis of standard nomograms incorporating age, sex, height, and weight. 25 CO 2 chemosensitivity measurement According to the CO 2 rebreathing method reported by Read, 26 we measured CO 2 chemosensitivity as follows. Breath by breath minute ventilation and end tidal CO 2 concentration were measured by the gas analyser system (AE-280, Minato Medical Science), and the data were stored in the computer hard disk for later analysis. We used custom made equipment consisting of a mouthpiece, an airway tube with a one way valve, and a 6 l bag, which initially contained a gas mixture of 7% CO 2 in 93% O 2 . After the subject quietly breathed room air for at least three minutes, a one way valve was switched for the rebreathing procedure. As the subject's expired gas was collected into the bag, the CO 2 concentration of the inspired gas from the bag was gradually increased, resulting in hyperventilation through stimulation of the hypercapnic chemoreceptor. Although subjects were asked to continue the procedure for four minutes, the test was terminated earlier if subjects had too strong a sensation of dyspnoea to continue the rebreathing or if end tidal CO 2 concentration exceeded 10%. CO 2 chemosensitivity was defined as the slope of the increase in minute ventilation relative to the increase in end tidal CO 2 concentration and was expressed in terms of l/min/mm Hg. Because CO 2 chemosensitivity reported by others varies considerably, 10 27 28 we examined age matched healthy subjects (n = 9, 62 (8) years old) without any cardiovascular disease.
Exercise training programme
Initial early sessions of the exercise training programme were conducted individually under close supervision for approximately the first two weeks during hospitalisation. Patients performed brisk walking on an indoor track and light bicycling at a heart rate of 20-30 beats/min above the resting rate. Subsequent standard training programme for 50-90 minutes consisted of bicycling and aerobic exercise (calisthenics, stretching, dancing) under the guidance of an exercise trainer. In this late phase, the exercise intensity was maintained at a heart rate of 50-60% of heart rate reserve, calculated from the resting and peak heart rate during the symptom limited exercise test. During each session, we continuously monitored the ECG to maintain each patient's individual training heart rate.
Statistical analysis
Data are expressed as mean (SD). We conducted linear univariate regression analysis to assess the significance of association between ṼE/ṼCO 2 and its possible correlates. To determine which of these factors were significant independent determinants of the ṼE/ṼCO 2 slope, we used multivariate regression analysis. Between group analysis was done by one way analysis of variance with Scheffé's test for multiple comparisons. The paired t test was used for comparisons within a group. Data were considered to be significantly different if p < 0.05 was observed.
RESULTS
At baseline, there was no significant difference between the training group (groups T High and T Low ) and group C with respect to age, male to female ratio, LVEF, incidence of Forrester's subset II or greater, or use of drugs (angiotensin converting enzyme inhibitors, β blockers, and digoxin), spirometric parameters, or peak ṼO 2 (table 1) . However, when the three groups were compared separately (groups T High , T Low , and C), peak ṼO 2 in group T High was significantly lower than that in group T High or group C (both p < 0.05). Trends towards higher age, greater male to female ratio, lower LVEF, and more frequent use of digoxin were also observed in group T High but these differences did not reach significance.
In nine age matched normal healthy subjects, hypercapnic CO 2 chemosensitivity was estimated to be 1.4 (0.4) l/min/ mm Hg. This value was quite similar to that of group C (1.3 (1.0) l/min/mm Hg) and group T LOW (1.3 (0.5) l/min/mm Hg) under baseline conditions (at entry into the exercise training programme). Only group T High (2.0 (0.7) l/min/mm Hg) had higher than normal values of CO 2 chemosensitivity (p < 0.05).
Baseline relation of variables of pulmonary function and CO 2 chemosensitivity to ṼE/ṼCO 2 slope In the 60 patients under the baseline conditions, three pulmonary function variables were all weakly but significantly correlated with the ṼE/ṼCO 2 slope during exercise (%TLCO, r = −0.33, p = 0.01; %VC, r = −0.28, p = 0.03; %FEV 1 , r = −0.30, p = 0.02) (fig 1) , while CO 2 chemosensitivity was relatively strongly correlated with the ṼE/ṼCO 2 slope (r = 0.62, p < 0.001). Peak ṼO 2 (r = −0.53, p < 0.001), age (r = 0.57, p < 0.001), and LVEF (r = −0.29, p = 0.03) were also significantly correlated with the ṼE/ṼCO 2 slope. ṼE/ṼCO 2 slope was not significantly affected by the presence or absence of acute phase haemodynamic impairment (subset II or greater of Forrester class). The multivariate regression model including the above six significant variables with p < 0.05 showed that age, %TLCO, and CO 2 chemosensitivity were significant independent variables; however, the association was most evident for CO 2 chemosensitivity (β = 0.49, p < 0.0001) compared with age (β = 0.29, p = 0.007) and %TLCO (β = −0.27, p = 0.008). These results suggest that CO 2 chemosensitivity has an important role in determining the ṼE/ṼCO 2 slope early after acute myocardial infarction, although multiple factors seem to be involved in the pathogenesis.
Changes in peak ṼO 2 and ṼE/ṼCO 2 slope Peak ṼO 2 and ṼE/ṼCO 2 slope did not change significantly in group C at the exercise testing after three months (table 2) . In 50 patients who completed the exercise training programme, peak ṼO 2 increased significantly from 21 (5) to 23 (5) ml/min/ kg after the three month training programme (p < 0.001). This improvement was similar in both subgroups (p < 0.01 for group T Low , p < 0.001 for group T HIGH ). The ṼE/ṼCO 2 slope was significantly attenuated in group T High (p < 0.001) but not in group T Low after three months compared with the baseline value. The changes in ṼE/ṼCO 2 slope for the whole group (30 (6.4) to 29 (6.0)) did not reach significance (p = 0.11).
Changes in CO 2 chemosensitivity and pulmonary function parameters After three months, CO 2 chemosensitivity in group C remained unchanged (1.3 (1.0) to 1.4 (1.3) /min/mm Hg, NS), while that in the training group was significantly attenuated from 1.6 (0.7) to 1.3 (0.6) l/min/mm Hg (p < 0.001) in the whole Figure 2 Relation between changes (∆) in the V E/V CO 2 slope and in CO 2 chemosensitivity, and between changes in the V E/V CO 2 slope and in spirometric parameters in the training group (n = 50). Changes in the V E/V CO 2 slope after three months were significantly correlated with changes in CO 2 sensitivity (r = 0.50, p < 0.001) but not with changes in spirometric parameters.
group. This attenuation was significant in both subgroups (p < 0.001 for group T Low , p < 0.001 for group T High ).
Among the three pulmonary function parameters, in the training group %VC and %TLCO increased significantly (both p < 0.05), while %FEV 1 remained unchanged. When analysed separately within each subgroup, significant changes were observed in %VC only in group T High (p < 0.05) and in %TLCO only in group T Low (p < 0.001). None of these three parameters was significantly different in group C.
Changes in ṼE/ṼCO 2 slope versus changes in CO 2 chemosensitivity and pulmonary function parameters In the 50 patients in the training group, the changes from baseline in the ṼE/ṼCO 2 slope after three months were significantly correlated with changes in CO 2 sensitivity (r = 0.50, p < 0.001). No such significant correlation was found for any of three pulmonary function variables (fig 2) . When analysed in the subgroups, the changes in the ṼE/ṼCO 2 slope were significantly correlated with changes in CO 2 chemosensitivity only in group T High (r = 0.64, p < 0.002) but not in group T Low (r = 0.33, p = 0.10) (fig 3) . These findings reasonably support the idea that attenuation in CO 2 chemosensitivity may have a central role in improving the exercise hyperventilation (that is, increased ṼE/ṼCO 2 slope) seen in patients after acute myocardial infarction.
DISCUSSION
Our previous study showed that an increased ṼE/ṼCO 2 slope (> 30) during exercise is seen in a substantial proportion (over 40%) of patients with acute myocardial infarction, in whom the increased slope was attenuated after three months' exercise training. 21 The present study has confirmed these results in a separate population. We aimed at exploring the mechanisms responsible for the above hitherto unknown issues and obtained the following results. (1) Among the three subgroups, only group T High with increased ṼE/ṼCO 2 relative to baseline had higher than normal CO 2 chemosensitivity. (2) Age, TLCO, and CO 2 chemosensitivity were independently related to the baseline ṼE/ṼCO 2 slope. (3) Regardless of the baseline level, CO 2 chemosensitivity was significantly attenuated after exercise training. Changes in the ṼE/ṼCO 2 slope after exercise training were significantly correlated only with changes in CO 2 chemosensitivity, not with any of the other parameters. These results suggest that, even in the absence of overt heart failure, ṼE/ṼCO 2 slope is increased in a significant proportion of postinfarct patients in association with aging, reduced TLCO, and enhanced CO 2 chemosensitivity, and that the increased ṼE/ṼCO 2 slope may be reduced by exercise training, at least partially, through the attenuation of CO 2 chemosensitivity. To our knowledge, in patients with heart disease, the possible role of CO 2 chemosensitivity in the improvement in increased ṼE/ṼCO 2 slope after exercise training has not been shown elsewhere.
Mechanisms for increased ṼE/ṼCO 2 slope
Although the detailed mechanisms underlying the increased ṼE/ṼCO 2 slope during exercise are still debated, multiple factors appear to be related to this phenomenon. Traditionally, these include a ventilation-perfusion mismatch underlying a limited increase in cardiac output and an increase in pulmonary dead space caused by rapid and shallow exercise breathing caused by decreased lung compliance. [3] [4] [5] [6] [7] [8] [9] However, a normal or near normal ṼE/ṼCO 2 slope is not uncommon in patients with the most severe left ventricular dysfunction, such as candidates for cardiac transplantation. Conversely, the ṼE/ṼCO 2 slope is often greatly increased in some patients with relatively preserved left ventricular function and no pulmonary disease. This notion is compatible with the wide ranges of ṼE/ṼCO 2 slope in previous studies examining patients with severe heart failure. 2 21 29 These findings suggest that exercise hyperventilation may be caused not only by severely depressed left ventricular function and inefficient ventilation (rapidshallow respiratory pattern caused by decreased lung compliance) but also by other mechanisms such as changes in exaggerated ergoreflex activity [11] [12] [13] [14] or alterations in the control of ventilation during exercise. Our results suggest that in cardiac patients the presence of chronic heart failure is not necessarily a prerequisite for increased ṼE/ṼCO 2 slope.
The present study has shown that, in patients after acute myocardial infarction, the ṼE/ṼCO 2 slope increases in association with aging, decreased TLCO, and enhanced CO 2 chemosensitivity. Among these three factors, enhanced CO 2 chemosensitivity seems to be the most potent determinant. The increase in ṼE/ṼCO 2 slope with aging was reported in healthy subjects. 30 Reduction of TLCO is well known in chronic heart failure. 15 16 31 In the study by Guazzi and colleagues 31 in which enalapril improved reduced TLCO in patients with chronic heart failure, changes in the ratio of dead space to tidal volume (a major determinant of the ṼE/ṼCO 2 slope) with enalapril were closely related to changes in TLCO. This may be in keeping with our finding that reduction of TLCO is a weak but significant independent determinant of the ṼE/ṼCO 2 slope in our patients; however, changes in TLCO after three months were not associated with changes in the ṼE/ṼCO 2 slope. Figure 3 Relation between changes in the V E/V CO 2 slope and in CO 2 chemosensitivity in the training subgroups (pretraining V E/V CO 2 <30 (group T Low , left) and pretraining V E/V CO 2 >30 (T High , right). Changes in the V E/V CO 2 slope were significantly correlated with changes in CO 2 chemosensitivity only in group T High (r = 0.64, p < 0.002), not in group T Low (r = 0.33, p = 0.10).
In our patients, the ṼE/ṼCO 2 slope was relatively strongly correlated with peak ṼO 2 , similar to reports from studies in patients with heart failure. 2 A weak but significant correlation between ṼE/ṼCO 2 slope and LVEF, which is not necessarily seen in chronic heart failure, may be explained by the wider distribution of LVEF (19-59%) in our population.
ṼE/ṼCO 2 slope in patients with acute myocardial infarction Although, as described above, several factors should contribute to the increased ṼE/ṼCO 2 slope in patients after myocardial infarction but without chronic heart failure, enhanced CO 2 chemosensitivity seems to be the most plausible mechanism. If this is the case, which mechanism can explain the enhanced CO 2 chemosensitivity in these patients? Although our study cannot explain it, it is conceivable that activation of the sympathetic nervous system after acute myocardial infarction enhances CO 2 chemosensitivity, which in turn increases the ṼE/ṼCO 2 slope. These patients are known to have heightened sympathetic tone, 32 33 which is reported to increase ventilation, [22] [23] [24] possibly by activation of the chemoreceptor. Another possible explanation is that an exaggerated muscle ergoreflex occurring with chronic physical deconditioning may be related to chemosensitivity activation. Further studies are necessary to confirm these issues.
Effects of exercise training
Given the importance of the contribution of enhanced CO 2 chemosensitivity to the increased ṼE/ṼCO 2 slope, one can suppose that some manipulations to reduce CO 2 chemosensitivity would improve the ṼE/ṼCO 2 slope, leading to an amelioration of breathlessness during exercise. A study by Chua and colleagues 34 examined this possibility with short term administration of dihydrocodeine. Of interest, the suppression of chemosensitivity with this agent was associated with a reduction of the ṼE/ṼCO 2 slope and an improvement in exercise tolerance (peak ṼO 2 ) and sensation of dyspnoea at a given work rate. 34 On the other hand, it is well established that chronic physical training attenuates increased ṼE/ṼCO 2 slope in patients with chronic heart failure, 17 18 whereas the ṼE/ṼCO 2 slope is shown to remain unchanged in normal subjects, 35 suggesting that the ṼE/ṼCO 2 slope may be altered only when the baseline level is increased. These findings are in agreement with our results-that is, the ṼE/ṼCO 2 slope was attenuated only in group T High with the increased baseline level of ṼE/ṼCO 2 slope.
Our finding that changes in the ṼE/ṼCO 2 slope after exercise training were correlated only with changes in CO 2 chemosensitivity supports the notion that attenuation of CO 2 chemosensitivity may have an important role in improving exercise hyperventilation. However, the causality of this relation remains to be solved. Unknown beneficial effects produced by chronic exercise, such as improvement of the activated neurohumoral systems, may directly influence both of these two changes. In the literature, there are few data showing exercise training induced attenuation of CO 2 chemosensitivity in cardiac patients. Although this issue has not yet been fully established even in the normal subjects, 36 the prevailing thought is that endurance training may attenuate CO 2 chemosensitivity.
Despite the presence of acute myocardial infarction, the mean values of CO 2 chemosensitivity in group C and group T Low were comparable with the mean value measured in healthy subjects. Only group T High had increased CO 2 chemosensitivity. The CO 2 chemosensitivity values in healthy subjects were somewhat lower than previously reported by other studies but were similar to the value reported by Yamamoto and colleagues. 37 Chemosensitivity is known to be lower in the elderly than in the younger subjects 38 and chemosensitivity varies considerably between individual subjects, which may have affected our results.
Clinical implications
Exercise training induced improvement of exercise hyperventilation may alleviate patient's dyspnoea during daily activities, as well as of exercise performance in patients with heart failure. The well established benefits of exercise training on exercise performance and quality of life in coronary artery disease may be partly brought about by the improvement in exercise hyperventilation. Exercise training has various benefits not only in the functional status of the peripheral organs but also in the regulation of the cardiocirculatory system, such as that seen by an improvement in autonomic imbalance (enhanced sympathetic drive and attenuated parasympathetic tone). It is possible that a similar central alteration of the control system of ventilation improves exercise hyperventilation, leading to amelioration of symptoms.
Study limitations
Several potential limitations of the present study should be considered. First, the present study was not designed as a randomised, controlled trial; the patients assigned to the control group (group C) underwent initial low grade exercise training during hospitalisation. The well established various benefits of a postinfarct exercise training programme could not ethically allow us to design the study in such a fashion. Although the training group and group C were well matched for all of the baseline parameters and none of the parameters changed significantly in group C after three months, this potential selection bias should be noted. The small number of patients in this group C should be recognised as one limitation of the study.
Although we defined the cut off value of 30 as an increased ṼE/ṼCO 2 slope according to our previous study, there is no consensus regarding this issue. Because multiple factors including aging, sex, and physical conditioning are likely to affect this value, its validity needs to be confirmed by further investigation.
To measure hypercapnic CO 2 chemosensitivity, we used the rebreathing method, which estimates both central and peripheral CO 2 chemosensitivity. Although both may have clinically important implications, we almost exclusively estimated the former because the peripheral hypercapnic chemosensitivity is known to be very small and negligible under the high oxygen concentration. 39 40 Although our patients generally had preserved LVEF, several patients had a low LVEF: five patients had LVEF < 30%, for example. Thus, we cannot completely exclude the possibility that our population may have included a number of patients with no overt but latent heart failure, especially in group T High , which trended towards a lower LVEF and a significantly reduced peak ṼO 2 compared with the other two groups. The lack of a universally accepted definition of heart failure is a problem; however, no patients with any signs or symptoms of heart failure were included in the study. Furthermore, when we reanalysed the data after excluding these five patients, the statistical results were exactly the same as those presented, supporting the idea that inclusion of patients with latent heart failure did not distort our results.
Conclusion
The present study indicated that, in patients with acute myocardial infarction, exercise hyperventilation as indicated by increased ṼE/ṼCO 2 slope during exercise occurs in association with aging, reduced TLCO, and hypercapnic CO 2 chemosensitivity. Among these three factors, chemosensitivity seems to be the most potent determinant of the abnormality. A subsequent three month supervised exercise training programme attenuates the increased ṼE/ṼCO 2 slope, at least partially, through the reduction of hypercapnic CO 2 chemosensitivity. We studied patients with acute myocardial infarction and no overt heart failure and thus cannot extrapolate these results to
